Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05707923 · ClinicalTrials.gov registry record · NA

How Simplified Language Affects Comprehension and Learning in Young Autistic Children

A NA study of Autism Spectrum Disorder, sponsored by Michigan State University.

Recruiting
Registry status
NA
Development phase
104
Enrollment target
1
Study location

NCT05707923: Recruiting NA study of Autism Spectrum Disorder, sponsored by Michigan State University.

NCT05707923 is a NA study of Autism Spectrum Disorder that is actively recruiting participants, run by Michigan State University. The registered enrollment target is 104 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05707923, a NA study of Autism Spectrum Disorder, is actively recruiting participants, sponsored by Michigan State University.

RECRUITING
Registry status
NA
Development phase
104 participants
Enrollment target
1
Study location

Study Summary

The long-term study goal is to experimentally evaluate the components (and likely active ingredients) of early language interventions for young children with ASD. The overall objective is to determine how single-word and telegraphic simplification affects real-time language processing and word learning in young children with ASD (relative to full, grammatical utterances). The proposed project will investigate three specific aims: 1) Determine how single-word and telegraphic simplification affects language processing. 2) Determine how single-word and telegraphic simplification affects word learning. 3) Evaluate child characteristics that may moderate the effects of linguistic simplification on language processing and word learning. Aim 1 will test the hypothesis that children with ASD will process full, grammatical utterances faster and more accurately than single-word or telegraphic utterances. Aim 2 will test the hypothesis that full, grammatical utterances will support word learning better than telegraphic or single-word utterances. Aim 3 will test the hypothesis that language and cognitive skills significantly moderate the effects of linguistic simplification on language processing and word learning in young children with ASD.

Primary Outcome

LWL involves a child looking at a screen with two images, one on each side of the screen, while being provided an auditory cue that includes the name of the target image. The primary outcome is a dichotomous variable indicating whether the child is fixated on the target image or the distracter image; gaze directed at neither image will be considered missing. It will be determined whether gaze is to the left or right image, using trained coders who are blind to target side. Gaze location will be

Conditions Studied

Interventions

  • BEHAVIORAL Linguistic simplification

Study Locations (1)

Michigan

  • Michigan State University - East Lansing

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2023-06-01
Est. Completion 2027-05-31
Phase NA
Michigan State University

120 total trials

What NCT05707923 shows while recruiting

NCT05707923 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (23% lower).

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Linguistic simplification is the first listed.

NCT05707923 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT05707923 about?

NCT05707923 is a clinical study titled "How Simplified Language Affects Comprehension and Learning in Young Autistic Children". The long-term study goal is to experimentally evaluate the components (and likely active ingredients) of early language interventions for young children with ASD. The overall objective is to determine how single-word and telegraphic simplification affects real-time language processing and word learn...

What is the current status of trial NCT05707923?

This trial is currently recruiting. It is a NA study. The enrollment target is 104 participants. The study started on 2023-06-01. Estimated completion is 2027-05-31.

What conditions does trial NCT05707923 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT05707923?

The interventions under investigation include: Linguistic simplification (BEHAVIORAL).

Who is sponsoring clinical trial NCT05707923?

This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05707923 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05707923's enrollment target sits among peer trials

104 70th of 224 higher than 155 of 224 other Autism Spectrum Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03403686 · 104 participants

    Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)

  • NCT04228367 · 104 participants · NA

    JuggerStitch Post Market Clinical Follow-up Study

  • NCT04268849 · 104 participants · Phase 3

    Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient

  • NCT04390724 · 104 participants

    Optimizing Y90 Therapy for Radiation Lobectomy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05707923, the US trial registry maintained by the National Library of Medicine. NCT05707923 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.